Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fell

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Nature Nanotechnology|March 16, 2024
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccinationYang C Zeng, Olivia J Young, Christopher M Wintersinger, et al.
The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Blood|September 12, 2022
Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19Peter G Miller, Geoffrey G Fell, Brody H Foy, et al.
Nature Nanotechnology|March 16, 2024
Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccinationYang C Zeng, Olivia J Young, Christopher M Wintersinger, et al.
The Lancet. Oncology|April 30, 2026
Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trialSeth A Wander, Maxwell R Lloyd, Jennifer C Keenan, et al.
Nature Cancer|June 3, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Nature Cancer|June 12, 2026
Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastomaJack Y Ghannam, Julian Bryan, Jakob Weiss, et al.
Pageof 7